Results of a Phase 1/2a dose–escalation study of FF-10501-01, an IMPDH inhibitor, in patients with acute myeloid leukemia or myelodysplastic syndromes-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Results of a Phase 1/2a dose–escalation study of FF-10501-01, an IMPDH inhibitor, in patients with acute myeloid leukemia or myelodysplastic syndromes

Published:2020-04-07 Issue:8 Volume:61 Page:1943-1953
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Garcia-Manero Guillermo¹,Pemmaraju Naveen¹,Alvarado Yesid¹,Naqvi Kiran¹,Ravandi Farhad¹,Jabbour Elias¹,De Lumpa Ricardo¹,Kantarjian Hagop¹,Advani Anjali²,Mukherjee Sudipto²,Gerds Aaron²,Carraway Hetty E.²,Nazha Aziz²,Iwamura Hiroyuki³,Murase Motohiko³,Bavisotto Linda⁴^ORCID,Kurman Michael⁴,Maier Gary⁴,Johansen Mary⁴,Sekeres Mikkael A.²

Affiliation:

1. Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA;

2. Leukemia Program, Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH, USA;

3. FUJIFILM Corporation, Tokyo, Japan;

4. FUJIFILM Pharmaceuticals U.S.A., Inc, Cambridge, MA, USA

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2020.1747065

Reference19 articles.

1. Hypomethylating agents in relapsed and refractory AML: outcomes and their predictors in a large international patient cohort

2. The efficacy of current prognostic models in predicting outcome of patients with myelodysplastic syndromes at the time of hypomethylating agent failure

3. Outcome of High-Risk Myelodysplastic Syndrome After Azacitidine Treatment Failure

4. Evaluation of induction chemotherapies after hypomethylating agent failure in myelodysplastic syndromes and acute myeloid leukemia

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Application of omics in the diagnosis, prognosis, and treatment of acute myeloid leukemia;Biomarker Research;2024-06-10

2. IMPDH inhibition activates TLR‐VCAM1 pathway and suppresses the development of MLL‐fusion leukemia;EMBO Molecular Medicine;2022-12

3. Metabolomics in acute myeloid leukemia;Molecular Genetics and Metabolism;2020-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3